St. Jude Medical Center Named One of America's Best Hospitals for Cancer Treatment

November 28, 2018

For the second year, St. Jude Medical Center has been named one of American’s Best Hospitals for cancer treatment by the Women’s Choice Award. The award—given to the top 9 percent of cancer programs in the U.S.—uniquely considers clinical quality, comprehensiveness of services and patient satisfaction, as well as women’s priorities in choosing a hospital.

“We’re very pleased to be recognized as one of the nation’s top cancer centers,” said David Park, MD, Medical Director of Oncology Services. “This honor drives home our unwavering commitment to safeguarding the physical and emotional health of every patient affected by cancer, from groundbreaking new therapies that allow us to improve outcomes, to one of the most comprehensive ranges of support services available anywhere.”

To be considered for the Women’s Choice Award, a hospital must have earned recognition as a Comprehensive Cancer Program by the American College of Surgeons’ Commission on Cancer—an elite designation that ensures a hospital offers a full range of diagnostic and treatment options, as well as evidence-based, quality-driven care. In addition, the Women’s Choice Award measures hospitals’ safety outcomes and the presence of specific cancer-related services. Hospitals are also given a numerical score based on patient satisfaction ratings from the Hospital Consumer Assessment of Health Care Providers and Systems (HCAHPS) Survey.

“Women will search on their own for the best cancer care,” said Delia Passi, CEO of the Women’s Choice Award. “According to surveys, nearly two-thirds of women would do their own research vs. letting a doctor chose a hospital for their cancer care. The Women’s Choice Award makes it easier for them to make confident decisions.”

“Earning the Women’s Choice Award is a testament to the success and collaboration of our highly trained experts in medical oncology, surgical oncology, diagnostic imaging, interventional radiology, radiation oncology, cancer research, and cancer rehabilitation,” explained Brian Helleland, Chief Executive, St. Jude Medical Center. “Together they offer the expertise and state-of-the-art care typically found only at the nation’s largest research hospitals, along with the compassion of a faith-based ministry that understands the power of genuine caring.”

In addition to designation as a Comprehensive Cancer Program by the American College of Surgeons’ Commission on Cancer, other criteria used by the Women’s Choice Award to determine the nation’s best hospitals include:

· Comprehensiveness of care: hospitals are evaluated on whether specific services—such as chemotherapy, radiation therapy, and ongoing research and clinical trials—are conveniently offered onsite.

· Safety: hospitals’ infection rates are considered, an important indication of patient safety, as oncology patients are more susceptible to hospital-acquired infections because of their compromised immune systems.

· Patient recommendation: The Women’s Choice Award uses patient satisfaction scores from the HCAPHPS Survey as part of its award methodology.

Passi emphasized that St. Jude Medical Center and the other 2018 America’s Best Hospitals for Cancer Care deliver on the criteria that matter most to women. “In addition to our award winners’ high level performance on a national level, they provide the care that women value most, including easily accessible services onsite to avoid multiple trips for their treatment, which is so important to women faced with a cancer diagnosis,” stated Passi.

For more information about the America’s Best Hospitals for Cancer Care, please visit

About the St. Jude Crosson Cancer Institute

As one of the nation’s top cancer treatment programs, the St. Jude Crosson Cancer Institute offers patients every advantage, from nationally-respected experts to today’s most exciting surgical, medical and therapeutic breakthroughs. Our award-winning cancer services include specialized centers of care in medical oncology and hematology, breast cancer, brain tumors, radiation oncology, digestive cancers, urologic and gynecologic cancers, thoracic and esophageal cancers, and clinical research, as well as a comprehensive and innovative list of support services.

In addition to highly trained cancer specialists, our integrated, multidisciplinary approach draws from numerous related fields, such as surgical oncology, interventional radiology, plastic and reconstructive surgery, cancer rehabilitation and others.

The St. Jude Crosson Cancer Institute is one of the specialty and tertiary centers of excellence at St. Jude Medical Center, a faith-based, non-profit hospital in Fullerton, California. Established 60 years ago by the Sisters of St. Joseph of Orange, the Magnet-designated hospital has earned a reputation for clinical excellence and nationally-recognized programs, including being named one of California's best hospitals by U.S. News & World Report. The hospital’s honors also include an “A” rating from The Leapfrog Group for meeting the nation’s highest patient safety standards, as well as being named an Advanced Comprehensive Stroke Center—one of only 150 in the nation—by The Joint Commission.

About the Women’s Choice Award

The Women’s Choice Award is a trusted referral source, empowering women to make smart healthcare choices by identifying the country’s best healthcare institutions based on criteria that consider patient satisfaction and clinical excellence. The Award’s methodology is objective, replicable and relies on the most recent publically available data. The Women’s Choice Award was recently honored by the INC 5000 List of America’s Fastest-Growing Private Companies for a third consecutive year. Visit to learn more.

Previous Article
St. Jude Offers "Game Changing" Surgical Technique for Malignant Brain Tumors
St. Jude Offers "Game Changing" Surgical Technique for Malignant Brain Tumors

A 66-year-old patient at St. Jude Medical Center became one of the first in the state to benefit from a bre...

Next Article
Providence Ventures Invests in Gauss Artificial Intelligence Technology to Identify Postpartum Bleeding Early
Providence Ventures Invests in Gauss Artificial Intelligence Technology to Identify Postpartum Bleeding Early

Providence Ventures today announced it has made an investment as part of a Series C $20M funding round for ...